Stockreport

Recursion to Participate in Upcoming Investor Conferences

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, annou [Read more]